WallStreetZenWallStreetZen

NASDAQ: CERS
Cerus Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CERS stock forecasts and price targets.

Forecast return on equity

Is CERS forecast to generate an efficient return?

Company
3.19%
Industry
20.76%
Market
342.13%
CERS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CERS forecast to generate an efficient return on assets?

Company
0.91%
Industry
11.72%
CERS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CERS earnings per share forecast

What is CERS's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.04
Avg 2 year Forecast
$0.01

CERS revenue forecast

What is CERS's revenue in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
$247.4M+9.46%
Avg 2 year Forecast
$271.1M+19.97%
CERS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CERS revenue growth forecast

How is CERS forecast to perform vs Medical Devices companies and vs the US market?

Company
9.46%
Industry
30.35%
Market
1,472.57%
CERS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CERS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CERS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CERS$2.06N/AN/A
CLPT$13.68N/AN/A
SGHT$7.93$9.22+16.27%Buy
RXST$10.42$9.44-9.37%Hold
BWAY$19.02$23.50+23.55%Buy
View Top Medical Device Stocks

Cerus Stock Forecast FAQ

What is CERS's earnings growth forecast for 2026-2027?

(NASDAQ: CERS) Cerus's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.29%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,192.97%.

Cerus's earnings in 2025 is -$15,964,000.On average, 6 Wall Street analysts forecast CERS's earnings for 2026 to be -$7,837,170, with the lowest CERS earnings forecast at -$20,707,033, and the highest CERS earnings forecast at $0.

In 2027, CERS is forecast to generate $1,959,293 in earnings, with the lowest earnings forecast at -$16,942,118 and the highest earnings forecast at $18,152,269.

If you're new to stock investing, here's how to buy Cerus stock.

What is CERS's revenue growth forecast for 2026-2027?

(NASDAQ: CERS) Cerus's forecast annual revenue growth rate of 9.46% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 30.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,472.57%.

Cerus's revenue in 2025 is $225,970,000.On average, 6 Wall Street analysts forecast CERS's revenue for 2026 to be $47,512,843,372, with the lowest CERS revenue forecast at $42,355,293,971, and the highest CERS revenue forecast at $50,301,953,887.

In 2027, CERS is forecast to generate $52,073,000,646 in revenue, with the lowest revenue forecast at $48,002,666,500 and the highest revenue forecast at $54,760,304,785.

What is CERS's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: CERS) forecast ROA is 0.91%, which is lower than the forecast US Medical Devices industry average of 11.72%.

What is CERS's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: CERS) Cerus's current Earnings Per Share (EPS) is -$0.08. On average, analysts forecast that CERS's EPS will be -$0.04 for 2026, with the lowest EPS forecast at -$0.11, and the highest EPS forecast at $0.00. In 2027, CERS's EPS is forecast to hit $0.01 (min: -$0.09, max: $0.09).

What is CERS's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: CERS) forecast ROE is 3.19%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.